dMMR-话题@MedSci

#dMMR#

0篇内容 | 966人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2264001, encodeId=9b562264001a6, content=<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a> <a href='/topic/show?id=192811136e69' target=_blank style='color:#2F92EE;'>#dMMR#</a>, objectTitle= 大咖谈 | MSI-H dMMR mCRC免疫进阶, objectType=article, longId=874524, objectId=ff098e45245e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PTE4SCK.jpg, objectUrl=/article/show_article.do?id=ff098e45245e, replyNumber=0, likeNumber=10, createdTime=2025-05-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ff098e45245e, moduleTitle= 大咖谈 | MSI-H dMMR mCRC免疫进阶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff098e45245e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2263196, encodeId=384a226319648, content=<a href='/topic/show?id=70e6139138a' target=_blank style='color:#2F92EE;'>#PD-1抑制剂#</a> <a href='/topic/show?id=192811136e69' target=_blank style='color:#2F92EE;'>#dMMR#</a>, objectTitle=不用开刀了！超80%患者恶性肿瘤完全消失，创新免疫疗法登顶刊, objectType=article, longId=874269, objectId=c5478e426980, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240625/1719284964871_5579292.jpg, objectUrl=/article/show_article.do?id=c5478e426980, replyNumber=0, likeNumber=22, createdTime=2025-05-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=c5478e426980, moduleTitle=不用开刀了！超80%患者恶性肿瘤完全消失，创新免疫疗法登顶刊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5478e426980)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2230762, encodeId=afbe2230e6293, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a> <a href='/topic/show?id=6bf49e844e9' target=_blank style='color:#2F92EE;'>#阿替利珠单抗#</a> <a href='/topic/show?id=192811136e69' target=_blank style='color:#2F92EE;'>#dMMR#</a>, objectTitle=Lancet Oncol | AtTEnd 试验：阿替利珠单抗联合化疗显著改善 dMMR 子宫内膜癌患者的无进展生存期, objectType=article, longId=846931, objectId=e22284693130, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401011/1728623819199_8538692.png, objectUrl=/article/show_article.do?id=e22284693130, replyNumber=0, likeNumber=64, createdTime=2024-10-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e22284693130, moduleTitle=Lancet Oncol | AtTEnd 试验：阿替利珠单抗联合化疗显著改善 dMMR 子宫内膜癌患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e22284693130)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188357, encodeId=fb5a218835e04, content=<a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a> <a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a> <a href='/topic/show?id=733811136610' target=_blank style='color:#2F92EE;'>#MSI-H #</a> <a href='/topic/show?id=192811136e69' target=_blank style='color:#2F92EE;'>#dMMR#</a>, objectTitle=大咖谈 | MSI-H/dMMR与妇科肿瘤, objectType=article, longId=812938, objectId=5ad381293886, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=5ad381293886, replyNumber=0, likeNumber=115, createdTime=2024-02-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5ad381293886, moduleTitle=大咖谈 | MSI-H/dMMR与妇科肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ad381293886)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

卵巢癌子宫内膜癌 MSI-H dMMR

2024-02-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#结直肠癌# #dMMR#

大咖谈 | MSI-H dMMR mCRC免疫进阶

2025-05-08发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#PD-1抑制剂# #dMMR#

不用开刀了！超80%患者恶性肿瘤完全消失，创新免疫疗法登顶刊

2025-05-02发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#子宫内膜癌# #阿替利珠单抗# #dMMR#

Lancet Oncol | AtTEnd 试验：阿替利珠单抗联合化疗显著改善 dMMR 子宫内膜癌患者的无进展生存期

2024-10-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#卵巢癌# #子宫内膜癌# #MSI-H # #dMMR#

大咖谈 | MSI-H/dMMR与妇科肿瘤

2024-02-20发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务